Home | Welcome to Contract Pharma   
Last Updated Wednesday, October 1 2014
Print RSS Feed

Scale-Up and Post-Approval Changes (SUPAC)



The FDA-recommended testing and filing actions to be taken by a pharmaceutical firm when it changes the manufacturing processes of a drug product that has already been approved via an NDA or ANDA.


blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On